[BACK]

Indication and Usage

• Fluzone vaccine is indicated for active immunization against influenza disease caused by influenza virus types A and B contained in the vaccine. It is indicated for people from 6 months of age and older
• Fluzone should be given yearly; beginning in September/October or as soon as the vaccine is available and continuing for as long as the influenza season and/or vaccine supply lasts.

• The Centers for Disease Control and Prevention (CDC)¹ recommends that the following groups of people should be immunized against influenza:


• Anyone who wants to prevent influenza
• Children 6 months-18 years of age
• People 50 years of age and older
• Women who will be pregnant during the influenza season
• Adults and children with chronic medical conditions, such as asthma, chronic obstructive pulmonary disease (COPD), heart disease, weakened immune system, diabetes, and others
• Residents of long-term care facilities and nursing homes
• If you are in contact with persons at high risk, you should also be vaccinated to prevent spreading the virus. These include:
  • Parents, siblings, grandparents, babysitters, and day care providers for children who are younger than 6 months of age
  • Health-care personnel
  • Household contacts and caregivers for people at risk of developing serious complications
  
  

Note: Children under 9 years of age receiving an influenza vaccination for the first time need 2 doses approximately 1 month apart.

Click to view recommended influenza immunization schedules

View full Prescribing Information for Fluzone vaccine. [MORE]

Indication
Fluzone vaccine is given for active immunization in persons 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

Safety Information
Side effects to Fluzone vaccine are soreness, pain, and swelling at the injection site; fever, fatigue, and muscular pain. Other side effects may occur. Fluzone vaccine should not be administered to anyone with a history of serious allergic reaction to any vaccine component, including eggs, egg products, or thimerosal (the only Fluzone vaccine product containing thimerosal is the multi-dose vial), or to persons who have been previously diagnosed with Guillain-Barré syndrome (GBS). If you notice any other problems or symptoms following vaccination, please contact your health-care professional immediately. Vaccination with Fluzone vaccine may not protect all individuals.
 
For more information about Fluzone vaccine, talk to your health-care professional.

Last modified: 11/16/09

[BACK]